Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Leases (2019 - 2025)

Marimed (MRMD) has disclosed Current Leases for 7 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Leases rose 1.59% to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.0 million, a 1.59% increase, with the full-year FY2024 number at $2.0 million, up 66.78% from a year prior.
  • Current Leases was $2.0 million for Q3 2025 at Marimed, up from $1.4 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2.0 million in Q4 2024 to a low of $27000.0 in Q4 2021.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2025 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: tumbled 97.32% in 2021, then skyrocketed 4614.81% in 2022.
  • Marimed's Current Leases stood at $27000.0 in 2021, then surged by 4614.81% to $1.3 million in 2022, then decreased by 4.95% to $1.2 million in 2023, then skyrocketed by 66.78% to $2.0 million in 2024, then fell by 1.78% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Current Leases are $2.0 million (Q3 2025), $1.4 million (Q2 2025), and $2.0 million (Q1 2025).